AUTL
Price
$1.32
Change
-$0.03 (-2.22%)
Updated
May 9 closing price
Capitalization
351.31M
81 days until earnings call
CABA
Price
$1.19
Change
-$0.02 (-1.65%)
Updated
May 9 closing price
Capitalization
60.38M
3 days until earnings call
Ad is loading...

AUTL vs CABA

Header iconAUTL vs CABA Comparison
Open Charts AUTL vs CABABanner chart's image
Autolus Therapeutics
Price$1.32
Change-$0.03 (-2.22%)
Volume$2.76M
Capitalization351.31M
Cabaletta Bio
Price$1.19
Change-$0.02 (-1.65%)
Volume$372.4K
Capitalization60.38M
AUTL vs CABA Comparison Chart
Loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUTL vs. CABA commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a StrongBuy and CABA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (AUTL: $1.32 vs. CABA: $1.19)
Brand notoriety: AUTL and CABA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 143% vs. CABA: 47%
Market capitalization -- AUTL: $351.31M vs. CABA: $60.38M
AUTL [@Biotechnology] is valued at $351.31M. CABA’s [@Biotechnology] market capitalization is $60.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 1 FA rating(s) are green whileCABA’s FA Score has 1 green FA rating(s).

  • AUTL’s FA Score: 1 green, 4 red.
  • CABA’s FA Score: 1 green, 4 red.
According to our system of comparison, both AUTL and CABA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 5 TA indicator(s) are bullish while CABA’s TA Score has 5 bullish TA indicator(s).

  • AUTL’s TA Score: 5 bullish, 3 bearish.
  • CABA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both AUTL and CABA are a good buy in the short-term.

Price Growth

AUTL (@Biotechnology) experienced а -2.22% price change this week, while CABA (@Biotechnology) price change was -11.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

AUTL is expected to report earnings on Jul 31, 2025.

CABA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($351M) has a higher market cap than CABA($60.4M). AUTL YTD gains are higher at: -43.830 vs. CABA (-47.577). CABA has higher annual earnings (EBITDA): -112.92M vs. AUTL (-202.12M). AUTL has more cash in the bank: 588M vs. CABA (183M). CABA has less debt than AUTL: CABA (15.2M) vs AUTL (52.6M). AUTL has higher revenues than CABA: AUTL (10.1M) vs CABA (0).
AUTLCABAAUTL / CABA
Capitalization351M60.4M581%
EBITDA-202.12M-112.92M179%
Gain YTD-43.830-47.57792%
P/E RatioN/AN/A-
Revenue10.1M0-
Total Cash588M183M321%
Total Debt52.6M15.2M346%
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUTLCABA
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
BTC.X104696.3300001725.468800
+1.68%
Bitcoin cryptocurrency
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with CRSP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-2.22%
CRSP - AUTL
48%
Loosely correlated
-1.44%
NTLA - AUTL
44%
Loosely correlated
-1.93%
RCKT - AUTL
44%
Loosely correlated
-0.71%
OCUL - AUTL
44%
Loosely correlated
-5.23%
SCPH - AUTL
43%
Loosely correlated
-2.79%
More

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with KYTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
-1.65%
KYTX - CABA
46%
Loosely correlated
-0.94%
ARWR - CABA
46%
Loosely correlated
-1.66%
IMNM - CABA
43%
Loosely correlated
-3.24%
AUTL - CABA
42%
Loosely correlated
-2.22%
CRSP - CABA
41%
Loosely correlated
-1.44%
More